Bioinformatics Market Size by Product and Services, Application, End User Sector, Region, Competitive Benchmarking & Forecast to 2034
Overview
Global Bioinformatics Market size was valued at USD 20.34 Bn in 2025 and is expected to reach USD 64.60 Bn by 2034, at a CAGR of 13.7%.
Bioinformatics Market Overview
Bioinformatics is an interdisciplinary field that incorporates computer science and biology to research, develop, and apply computational tools. This approach is used to manage and process large sets of biological data. Its primary objective is to understand complex biological processes, genetic variations, and molecular interactions by harnessing the power of computational tools and algorithms. The integration of biological data with computational techniques has revolutionized various areas of research, including genomics, proteomics, systems biology, and drug discovery. Bioinformatics utilizes modern computer science that includes cloud computing, statistics, mathematics, and even pattern recognition, reconstruction, machine learning, simulation and iterative approaches, and molecular modeling/algorithms.
The development of new personalized medicine, drug discovery, precision agriculture, synthetic biology, and environmental biotechnology are driving key factors for the Bioinformatics Market. Advancements in AI, data integration, and ethical considerations are expected to improve bioinformatics' impact on healthcare, agriculture, and the environment, making it a convincing investment opportunity with significant social and scientific impact.
Global Bioinformatics Market Size and Growth Forecast
To know about the Research Methodology :- Request Free Sample Report
Bioinformatics Market Dynamics: Growth Driver, Opportunity, Restrain Factor
Advancements in Genomics and Next-Generation Sequencing (NGS) to Boost Market Growth
Genomics provides key benefits to the healthcare system through clinical research and drug development, personalizing treatment regimens, and improving patient outcomes. The advancement in genomics is a key driver for the Bioinformatics Market growth. Also, it has the potential to reshape drug discovery and development moving the life sciences industry. Genomic data, the most personal of all human data, is part of the overall explosion in health data, which is enabled by the exponential growth in computing power and the commercialization of wearable technologies such as smartphones, fitness trackers and heart rate monitors. Managing this data is expected to change the way such information is gathered, stored, analyzed and used with privacy, reliability, and security posing prickly challenges. The significant progress in genomics research and the adoption of NGS technologies has increased biological data generation. For instance, Genomics England, a company set up by the UK’s Department of Health & Social Care, is carrying out the 100,000 Genomes Project, which aims to sequence 100,000 genomes from around 70,000 people with rare diseases, plus their families, as well as from patients with cancer.
In 2022-2023, the global next-generation sequencing (NGS) market was $12.46 billion. This growth is driven by advancements in platform technology, increasing applications of sequencing, growth in partnerships and collaborations, increasing adoption of NGS among research laboratories and academic institutes, and the decline in the cost of sequencing.
Top Global Genome Sequencing Companies by Revenue that Use Wider Technology Help to Drive NGS Growth:
| Companies | Applications Sectors | Key Developments |
| Thermo Fisher Scientific | Leaders in serving science and products used in genomic sequencing including instruments, reagents, and software with the application are: 1. Cancer Research 2. Drug Development 3. Agricultural Biotechnology |
Oncomine Dx Target Test, which is the first NGS-based companion diagnostic to aid in therapy selection for patients with RET mutations/fusions in thyroid cancers. |
| BGI Genomics | The company offers sequencing services and products for genome sequencing, genotyping, and genetic diagnosis. 1. Cancer Research 2. Drug Development 3. Agricultural Biotechnology |
Their plan is to provide the BGI/Natera Signatera Assay worldwide. The assay is designed to provide access to personalized ctDNA testing for patients and healthcare providers as well as to support cancer research and drug development. |
| Agilent Technologies | Agilent's products application: 4. Cancer Research 5. Drug Development 6. Agricultural Biotechnology |
The company announced a partnership with Mytide Therapeutics with a focus on automation, reliability and data quality issues across the peptide industry. |
| Illumina | Leader in sequencing services and sells both instruments and reagents for genome sequencing and applications are: 1. Diagnostics, 2. Cancer Research, 3. Drug Development 4. Agricultural Biotechnology |
Revolutionary NovaSeq X series platform, which it claims will be able to sequence over 20,000 genomes per year. |
| Qiagen | Leading providers of genomic sequencing services, products and solutions including instruments, reagents, and software applications are: 1. Diagnostics 2. Drug development |
Launch of the QIAstat-Dx Viral Vesicular Panel, a new syndromic test that is designed to combat the global health emergency of monkeypox. |
In 2022-23, the pharmaceutical industry spent $83 billion dollars on R&D. The amount of money that drug companies provide to R&D is determined by the amount of revenue they expect to earn from a new drug, the expected cost of developing that drug, and policies that influence the supply of and demand for drugs.
Demand growth for genomic sequencers from medical researchers has been augmented by demand from healthcare providers as applications have expanded from research labs to clinical providers. Governments and consumers are the next source of strong demand growth. This is a technology with high barriers to entry where market leaders boost their market share.
The advent of personalized medicine for pharmaceutical companies to reconsider their current business model. The blockbuster model gives way to drug therapies tailored to individual patients. This has required that drugs move through the pipeline faster, are more effective, safer and less costly to develop. Personalized medicine is in essence precision medicine and predictive medicine. Companies that produce the tools and technology, such as companion diagnostics, that facilitate better information, better outcomes and lower costs will become increasingly valuable.
Increase in Demand for Personalized Medicine and Pharmacogenomics to Create Lucrative Opportunity for the Market
The new shift toward personalized medicine due to the increase in polypharmacy patients across the world is expected to influence the demand for personalized medicine and drive the market growth potential. The implementation of personalized medicine requires a confluence of multiple factors such as regulation, patient education, integral property, refreshment, R& D incentives and competitive effectiveness research. Full implementation of personalized medicine is expected to pose a challenge to the Bioinformatics Market growth over the forecast period. Also, big data analytics and AI integration into bioinformatics and data-intensive research as well as a solution are expected to create lucrative opportunities for the market growth potential.
Pharmacogenomics presents an opportunity for rapid translation of associated genetic polymorphisms into diagnostic measures or tests to guide therapy as part of a move towards personalized medicine. The rising importance of personalized medicine and pharmacogenomics is expected to drive the demand for bioinformatics solutions globally. However, bioinformatics has the potential to identify drug targets, prediction of drug responses based on genetic variations, and optimization of drug candidates. Pharmaceutical companies are incorporating bioinformatics approaches to develop targeted therapies for precision medicine. This trend is expected to influence the Bioinformatics Market growth.
Data Security and Privacy Concerns
Bioinformatics deals with sensitive and personal information, such as genomic data, health records, and patient information. As the volume of data being generated and shared in the healthcare and life sciences sectors grows and increasing concern about data security and privacy. This leads the key challenge for the market. However, the lack of standardization and interoperability among different bioinformatics platforms and databases is another challenge for the Bioinformatics Market expansion.
The high costs associated with the required infrastructure and bioinformatics tools is restraining factor for the Bioinformatics Industry growth. The field of bioinformatics heavily relies on computational resources, high-performance computing clusters, and specialized software and algorithms.
Bioinformatics Market Segment Analysis
1. By Product and Services
Bioinformatics Platforms held the leading position in the global bioinformatics market in 2025, supported by increasing demand for integrated computational tools that enable researchers and biotechnology companies to manage, analyse, and interpret large volumes of biological data. Platforms combine databases, analytical software, visualization capabilities, and computational workflows, making them useful across genomics, proteomics, transcriptomics, and drug-discovery activities. Bioinformatics Services are also gaining importance as pharmaceutical and biotechnology companies increasingly outsource data analysis, algorithm development, database management, and specialized computational work to external providers. Knowledge Management Tools support the organization, retrieval, and interpretation of biological information and remain relevant for research institutions and life-science organizations handling complex datasets.
2. By Application
Genomics accounted for the leading share of the global bioinformatics market in 2025, driven by the expanding use of genomic sequencing, variant analysis, personalized medicine, and genomic research. The growing volume of sequencing data has increased the requirement for computational platforms capable of processing and interpreting complex genomic information. Proteomics and transcriptomics also represent important applications, as researchers increasingly integrate protein-expression and gene-expression data to understand disease mechanisms and identify therapeutic targets. Metabolomics, molecular phylogenetics, and chemoinformatics further contribute to demand across drug discovery, biomarker research, evolutionary studies, and molecular analysis.
Regional Analysis – Global Bioinformatics Market
North America held the leading position in the Global Bioinformatics Market in 2025, supported by strong pharmaceutical and biotechnology R&D, advanced genomic research, next-generation sequencing, precision medicine, and high adoption of bioinformatics platforms and computational tools. The United States remains the major contributor, with increasing demand for genomic data analysis, biological databases, drug discovery, and AI-enabled bioinformatics.
Europe represents a major regional market, driven by pharmaceutical research, personalized medicine, molecular diagnostics, genomics, proteomics, and expanding biotechnology activities. Strong research institutions and healthcare infrastructure across Germany, the United Kingdom, France, and other European countries are supporting the adoption of sequencing technologies, bioinformatics software, and data-analysis solutions.
Asia Pacific is expected to register the fastest growth through 2034, supported by expanding biotechnology and pharmaceutical industries, increasing genomic sequencing, healthcare digitization, and rising investments in precision medicine. China, India, Japan, South Korea, and Australia are strengthening their genomics infrastructure, creating demand for cloud-based bioinformatics, data mining, machine learning, and computational biology.
South America is an emerging market, with growth supported by increasing genomic research, molecular diagnostics, agricultural biotechnology, pharmaceutical research, and healthcare investment. Brazil and Argentina are important contributors, while universities, research institutes, and biotechnology companies are increasing the use of genomic sequencing, biological databases, and bioinformatics analytical tools.
Middle East & Africa is a developing market supported by healthcare modernization, national genomics initiatives, biotechnology investment, genetic testing, and precision medicine. Countries such as Saudi Arabia and the UAE are expanding genomic research and advanced healthcare infrastructure, creating opportunities for bioinformatics platforms, genomic data analysis, cloud computing, and specialized bioinformatics services.
Bioinformatics Market Competitive Landscape:
The dynamic Global Bioinformatics Market growth is driven by AI integration, personalized medicine applications, and cloud-based solutions. Key players including Illumina, Thermo Fisher Scientific, and DNAnexus lead the industry, emphasizing research and development, strategic collaborations, and data security to stay competitive. However, the market poses challenges related to data privacy and market consolidation. To thrive, companies must focus on innovation, user-friendly interfaces, and customer support while exploring new markets and adopting competitive pricing strategies. Overall, the report provides bioinformatics companies need to remain adaptable and customer-centric to seize opportunities and drive advancements in life sciences.
Bioinformatics Industry participants are involved in the R&D of genetic and proteomic sequencing to improve DNA, and RNA sequencing capabilities to further reduce the costs of genome sequencing. The development of next-generation sequencing technologies is expected to drive the bioinformatics industry over the forecast period.
Bioinformatics Market Scope: Inquire Before Buying
| Bioinformatics Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 20.34 USD Bn |
| Forecast Period 2026-2034 CAGR: | 13.7% | Market Size in 2034: | 64.60 USD Bn |
| Segments Covered: | by Product and Services | Knowledge Management Tools Bioinformatics Platforms Bioinformatics Services |
|
| by Technology | Sequencing Technology Microarray Technology Mass Spectrometry High-Throughput Screening Data Mining & Machine Learning Structural Bioinformatics Tools |
||
| by Deployment Model | Cloud-Based Bioinformatics On-Premise Bioinformatics Systems Hybrid Deployment |
||
| by Database Type | Biological Databases Protein Databases DNA Databases Nucleotide Databases Chemical Databases |
||
| by Application | Metabolomics Molecular Phylogenetics Transcriptomics Proteomics Chemoinformatics Genomics Others |
||
| by End User Sector | Pharmaceutical and Biotechnology Companies Medical Biotechnology Animal Biotechnology Agriculture Biotechnology Academic and Research Institutes Healthcare Providers Others |
||
Bioinformatics Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Bioinformatics Key Players are:
North America
1. Thermo Fisher Scientific Inc. (USA)
2. Agilent Technologies Inc. (US)
3. Illumina Inc. (US)
4. Waters Corporation (US)
5. NeoGenomics Laboratories (US)
6. Perkin Elmer Inc. (US)
7. Seven Bridges Genomics, Inc. (US)
8. Station X, Inc. (US)
9. Active Motif, Inc. (US)
10. Bio-Rad Laboratories, Inc. (US)
Europe
11. Eurofins Scientific (Luxembourg)
12. QIAGEN N.V.(Netherlands)
13. Fios Genomics (UK)
14. Source BioScience (UK)
15. Genedata AG (Switzerland)
16. Eurofins Scientific SE (Luxembourg)
17. Genomatix Software GmbH (Germany)
18. Dassault Systèmes Biovia Corp. (France)
19. Sophia Genetics SA (Switzerland)
Asia Pacific
20. BGI Genomics Co., Ltd. (China)
Others
Frequently Asked Questions – Global Bioinformatics Market
1. What is the size of the Global Bioinformatics Market in 2025?
The Global Bioinformatics Market was valued at approximately USD 20.34 Billion in 2025.
2. What is the expected CAGR of the Global Bioinformatics Market through 2034?
The Global Bioinformatics Market is projected to expand at a CAGR of 13.7% during 2026–2034, supported by rising genomic research, next-generation sequencing, precision medicine, and computational biology applications.
3. Which region dominates the Global Bioinformatics Market?
North America dominated the Global Bioinformatics Market in 2025, supported by advanced biotechnology and pharmaceutical research, genomic infrastructure, bioinformatics software adoption, and strong investment in precision medicine.
4. Which region is expected to grow fastest in the Global Bioinformatics Market?
Asia Pacific is expected to register the fastest growth during the forecast period, driven by expanding biotechnology and pharmaceutical industries, genomic sequencing, healthcare digitization, and increasing adoption of AI and cloud-based bioinformatics.
5. What are the major applications of bioinformatics?
Major applications include genomics, proteomics, transcriptomics, metabolomics, chemoinformatics, and molecular phylogenetics. Among these, genomics represents a major application because of increasing sequencing activity and the growing volume of genomic data requiring computational analysis.